immunotherapy101.com immunotherapy101.com

IMMUNOTHERAPY101.COM

BioMedical Learning Institute

Independent Continuing Medical Education for Physicians, Pharmacists, and Nurses. BMLI offers live and web-based oncology CME/CE activities.

http://www.immunotherapy101.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IMMUNOTHERAPY101.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.8 out of 5 with 12 reviews
5 star
6
4 star
1
3 star
3
2 star
0
1 star
2

Hey there! Start your review of immunotherapy101.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.3 seconds

FAVICON PREVIEW

  • immunotherapy101.com

    16x16

  • immunotherapy101.com

    32x32

  • immunotherapy101.com

    64x64

  • immunotherapy101.com

    128x128

  • immunotherapy101.com

    160x160

  • immunotherapy101.com

    192x192

  • immunotherapy101.com

    256x256

CONTACTS AT IMMUNOTHERAPY101.COM

BMLI

Stephen Madison

6809 Ce●●●●●●●e Court

Pl●●no , Texas, 75093

United States

1.21●●●●2010
st●●●●●●●●●●●●●@bmli.com

View this contact

BMLI

Stephen Madison

6809 Ce●●●●●●●e Court

Pl●●no , Texas, 75093

United States

1.21●●●●2010
st●●●●●●●●●●●●●@bmli.com

View this contact

BMLI

Stephen Madison

6809 Ce●●●●●●●e Court

Pl●●no , Texas, 75093

United States

1.21●●●●2010
st●●●●●●●●●●●●●@bmli.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2014 February 16
UPDATED
2014 April 11
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 11

    YEARS

  • 8

    MONTHS

  • 18

    DAYS

NAME SERVERS

1
ns73.domaincontrol.com
2
ns74.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

SCORE

6.2

PAGE TITLE
BioMedical Learning Institute | immunotherapy101.com Reviews
<META>
DESCRIPTION
Independent Continuing Medical Education for Physicians, Pharmacists, and Nurses. BMLI offers live and web-based oncology CME/CE activities.
<META>
KEYWORDS
1 cancer education
2 wwwbmli com
3 future activities
4 online webinars
5 resources
6 archives
7 library
8 cancer meeting calendar
9 coupons
10 reviews
CONTENT
Page content here
KEYWORDS ON
PAGE
cancer education,wwwbmli com,future activities,online webinars,resources,archives,library,cancer meeting calendar
SERVER
Apache/2.4.18 (Fedora) OpenSSL/1.0.1k-fips PHP/5.6.23
POWERED BY
PHP/5.6.23
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

BioMedical Learning Institute | immunotherapy101.com Reviews

https://immunotherapy101.com

Independent Continuing Medical Education for Physicians, Pharmacists, and Nurses. BMLI offers live and web-based oncology CME/CE activities.

INTERNAL PAGES

immunotherapy101.com immunotherapy101.com
1

BioMedical Learning Institute

http://www.immunotherapy101.com/archives.php

Taught by the Experts. Let us manage your CME hours. Future Meetings and Conferences. 1st Annual Symposium on Integrating Immune and Targeted Therapies. 9th Personalized Therapies for Lung Cancer. The Management of Elderly Patients with Malignancies. Weight Loss in Patients with Lung Cancer. Integrating Immuno-Oncology Into Therapy for Lung Cancer. Great Debates in Lung Cancer. The New Frontier in NSCLC Beyond EGFR, VEGF, and ALK. Login or Create Account. ASCO 2010: Emerging Novel Strategies for Personal...

2

BioMedical Learning Institute

http://www.immunotherapy101.com/index.php

Taught by the Experts. Let us manage your CME hours. Future Meetings and Conferences. 1st Annual Symposium on Integrating Immune and Targeted Therapies. 9th Personalized Therapies for Lung Cancer. The Management of Elderly Patients with Malignancies. Weight Loss in Patients with Lung Cancer. Integrating Immuno-Oncology Into Therapy for Lung Cancer. Great Debates in Lung Cancer. The New Frontier in NSCLC Beyond EGFR, VEGF, and ALK. Login or Create Account. All Available Oncology/Hematology CME/CE Courses.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

2

SOCIAL ENGAGEMENT



OTHER SITES

immunotherapy.ascia.org.au immunotherapy.ascia.org.au

ASCIA allergen immunotherapy e-training

Skip to main content. AITeTHP 2014 Course Home. ASCIA www.allergy.org.au. ASCIA allergy and anaphylaxis Active Learning Module. ASCIA anaphylaxis e-training for health professionals. ASCIA anaphylaxis e-training for pharmacists. ASCIA food allergy e-training. ASCIA allergic rhinitis e-training for health professionals. Enrol and complete course. The development of this course has been supported by an educational grant from:. Medical images provided by:. Course website produced by. ASCIA allergen immunoth...

immunotherapy.bajamedical.net immunotherapy.bajamedical.net

bajamedical.net

Inquire about this domain.

immunotherapy.jp immunotherapy.jp

がんの免疫療法なら湘南メディカルクリニック新宿院

さらに当院は培養関係企業との、共同研究 共同開発を行っていますので情報 知識 技術の向上を絶やさず治療に活かしています。 201508.17 がん情報コラム オプジーボでがん治療が変わる を更新致しました。 201508.11 がん情報コラム 抗PD-1抗体は皮膚の副作用がある方がいい を更新致しました。 201508.10 がん情報コラム 重粒子線治療は効かない を更新致しました。 201508.05 がん情報コラム 医者が言う余命は3割も当らない を更新致しました。 201508.04 がん情報コラム 日本人男性のがんで大腸が初の1位に を更新致しました。 201507.21 がん情報コラム 肝がん手術は症例数が多い病院ほど死亡率が低い を更新致しました。 201507.17 がん情報コラム 50代働き盛りの命を奪う胆管がんとは を更新致しました。 201507.16 がん情報コラム C型肝炎のインターフェロン フリー療法は、3カ月でなんと500万円 を更新致しました。 201507.15 がん情報コラム C型肝炎ウイルス排除後に残る発がんリスク を更新致しました。

immunotherapy.org immunotherapy.org

immunotherapy.org

The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).

immunotherapy.riken.jp immunotherapy.riken.jp

免疫細胞治療研究チーム

その為に私達は、抗原提示細胞である樹状細胞に標的腫瘍の特異的抗原を発現させ体内に戻す従来のex vivo療法と異なり、 生体内の樹状細胞を利用するin vivo療法の開発を進めております. 新規がんワクチン 人工アジュバントベクター細胞の開発 が、2014年度に続き2015年度も文部科学省 橋渡し研究支援推進 プログラム 東京大学橋渡し拠点 に採択され、前臨床試験を進めております。 術後非小細胞肺癌を対象としたNKT細胞療法 第II相試験 を国立病院機構 九州がんセンターおよび名古屋医療センター と共同研究で進めております。 悪性リンパ腫における骨髄由来の免疫抑制細胞 MDSC細胞 のサブセットと役割をヒト マウスにおいて明らかにし、その成果が Oncoimmunology. Proceedings of the National Academy of Sciences of the United States of America.

immunotherapy101.com immunotherapy101.com

BioMedical Learning Institute

Taught by the Experts. Let us manage your CME hours. 11th Personalized Therapies for Lung Cancer. Personalized Therapies in Lung Cancer 2018. Integrating Immune Therapies 2018. 2018 BioMedical Learning Institute. Phone: (214) 269-2014 · Contact Us.

immunotherapy4cancer.com immunotherapy4cancer.com

www.immunotherapy4cancer.com

immunotherapycancer.ca immunotherapycancer.ca

CCIC | Canadian Cancer Immunotherapy Consortium

Vancouver, BC, June 18-20, 2018. Next CCIC Meeting: Vancouver, BC, June 18-20, 2018. On behalf of the Canadian Cancer Immunotherapy Consortium (CCIC) and ImmunoBC, we are delighted to announce a Joint Meeting of CCIC and ImmunoBC 2018, which will take place in Vancouver BC from June 18-20, 2018.This exciting partnership brings together the 11th Annual CCIC and the 10th Annual ImmunoBC symposia for 3 days of cross-disciplinary presentations and dialogue. Mark Davis – Stanford University. 138 Victory Ship ...

immunotherapycancer.com immunotherapycancer.com

immunotherapycancer.com

immunotherapycancerresearch.com immunotherapycancerresearch.com

Prevor Family Fund

PLEASE CLICK ON THE LOGO ABOVE TO DONATE.

immunotherapycancerresearch.org immunotherapycancerresearch.org

Prevor Family Fund

PLEASE CLICK ON THE LOGO ABOVE TO DONATE.